| Literature DB >> 31158804 |
Marianthi Breza1, Georgios Koutsis2, John S Tzartos3, Georgios Velonakis4, Maria Eleftheria Evangelopoulos5, Dimitrios Tzanetakos5, Katerina Karagiorgou6, Georgia Angelopoulou7, Dimitrios Kasselimis8, Constantin Potagas9, Maria Anagnostouli10, Leonidas Stefanis11, Constantinos Kilidireas12.
Abstract
MOG-antibody associated demyelinating disease is a new emerging diagnostic entity. Recently, international recommendations for testing of anti-MOG antibodies were published. Herein, we describe a case of anti-MOG antibody-associated demyelinating disease initially diagnosed as typical MS, and, at presentation, not fulfilling the proposed recommendations. This case highlights the expanding spectrum of anti-MOG antibody-associated demyelinating disease, illustrating the distinct and overlapping features of MS and MOG-antibody associated demyelinating disease, providing evidence that on rare occasions these recommendations may prove too restrictive.Entities:
Keywords: Anti-MOG antibodies; Anti-MOG antibody testing; MOG antibody-associated demyelination; Multiple sclerosis
Mesh:
Substances:
Year: 2019 PMID: 31158804 DOI: 10.1016/j.msard.2019.05.021
Source DB: PubMed Journal: Mult Scler Relat Disord ISSN: 2211-0348 Impact factor: 4.339